Shahab Babakoohi, MD

Drs Babakoohi and Atlas share clinical pearls for community oncologists on treating basal cell carcinoma.

A look at how common metastatic basal cell carcinoma is in clinical practice and when to consider frontline immunotherapy.

Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.

Jennifer Atlas, MD, presents the case of a 66-year-old woman with locally advanced basal cell carcinoma not responding to frontline treatment.

Shahab Babakoohi, MD, describes his monitoring strategies for patients with basal cell carcinoma.

Dr Jennifer Atlas leads a conversation on systemic therapy options in basal cell carcinoma with a review of clinical trial data.

Experts review the currently available treatment options for locally advanced basal cell carcinoma.

Dr. Shahab Babakoohi explains when to refer a patient with basal cell carcinoma from a dermatology practice to a medical oncologist.

Jennifer Atlas, MD, presents the clinical scenario of a man with locally advanced basal cell carcinoma.

Shahab Babakoohi, MD, describes the incidence patterns, options for testing and diagnosis, and risk stratification for basal cell carcinoma.